Current Perspective in Mixed Pain
Abstract
Pain is one of the 10 leading causes of medical consultation worldwide and is the alarm symptom of the organism in situations that threaten its integrity, however, when it becomes chronic, it loses its protective capacity and becomes, in many cases, the disease itself.
According to the International Association for the Study of Pain (IASP) pain is classified as nociceptive, neuropathic and nociplastic. Mixed pain has been described years ago due to the coexistence of different types of pain.
We can conclude that we do not have a screening tool and/or treatment algorithm for mixed pain, so it is preferable that pain management begins with a rigorous assessment, using the latest available tools, followed by individualized evidence-based treatment with multimodal therapy when appropriate.
Keywords: nociceptive pain, neuropathic pain, mixed pain.
Keywords:
nociceptive pain, neuropathic pain, mixed painDOI
https://doi.org/10.22270/jddt.v14i3.6451References
Guillén-Núñez MR, Juárez-Lemus AM. Algología para no algólogos, Siegfried Rhein, 2020; 15-24.
Freynhagen R, Parada HA, Calderon-Ospina CA, Chen J, Rakhmawati Emril D, Fernández-Villacorta FJ, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35(6):1011-1018. https://doi.org/10.1080/03007995.2018.1552042 PMid:30479161
Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC, Rief W, Sluka AK. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. https://doi.org/10.1097/j.pain.0000000000000507 PMid:26835783
Benaña J. Dolor neuropático: actualización en definiciones y su tratamiento farmacológico. Rev Med Hondur; 2020; 88(1): 48-51. https://doi.org/10.5377/rmh.v88i1.11591
Trouvin AP, Perrot S. New concepts of pain. Best Pract Res Clin Rheumatol. 2019;33(3):101415. https://doi.org/10.1016/j.berh.2019.04.007 PMid:31703792
Argoff C. Distinguishing Neuropathic, Non-Neurophatic, and Mixed Pain. Pract Pain Manag, 2017;17(1).
Baron R, Binder A, Attal N, Casale R, Dickenson AH, Treede RD. Neuropathic low back pain in clinical practice. Eur J Pain. 2016;20(6):861-873. https://doi.org/10.1002/ejp.838 PMid:26935254 PMCid:PMC5069616
Ito S, Kobayashi D, Murasawa A, Narita I, Nakazono K. An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients. Intern Med. 2018;57(4):479-485. https://doi.org/10.2169/internalmedicine.9235-17 PMid:29225253 PMCid:PMC5849541
Ibor PJ, Sánchez-Magro I, Villoria J, Leal A, Esquivias A. Mixed Pain Can Be Discerned in the Primary Care and Orthopedics Settings in Spain: A Large Cross-Sectional Study. Clin J Pain. 2017;33(12):1100-1108. https://doi.org/10.1097/AJP.0000000000000491 PMid:28244943
Perrot S. Osteoarthritis pain. Best Pract Res Clin Rheumatol 2015; 29:90-97. https://doi.org/10.1016/j.berh.2015.04.017 PMid:26267003
Zolio L, Lim KY, McKenzie JE, Yan MK, Estee M, Hussain SM, Cicuttini F, Wluka A. Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis. Osteoarthritis Cartilage. 2021;29(8):1096-1116. https://doi.org/10.1016/j.joca.2021.03.021 PMid:33971205
Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following who guidelines. Pain. 1999 Jan 1;79(1):15-20. https://doi.org/10.1016/S0304-3959(98)00138-9 PMid:9928771
Fainsinger RL, Nekolaichuk C, Lawlor P et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010;46:2896-904. https://doi.org/10.1016/j.ejca.2010.04.017 PMid:20483589
Bennett MI, Rayment C, Hjermstad M, Aass N et al. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 Feb;153(2):359-365. https://doi.org/10.1016/j.pain.2011.10.028 PMid:22115921
Reis-Pina P, Acharya A, Lawlor, P. Cancer pain with a neuropathic component: a cross-sectional study of its clinical characteristics, associated psychological distress, treatments, and predictors at referral to a cancer pain clinic. Journal of pain and symptom management, 2018, 55(2), 297-306. https://doi.org/10.1016/j.jpainsymman.2017.08.028 PMid:28870800
Higashibata T, Tagami K, Miura T, Okizaki A, Watanabe Y et al. Usefulness of painDETECT and S-LANSS in identifying the neuropathic component of mixed pain among patients with tumor-related cancer pain. Supportive Care in Cancer, 2020: 28(1), 279-285. https://doi.org/10.1007/s00520-019-04819-9 PMid:31041583
Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111(1):105-111. https://doi.org/10.1093/bja/aet208 PMid:23794652
Freynhagen R, Rey R, Argoff Ch. When to consider "mixed pain"? The right questions can make a difference! Current Medical Research and Opinion, 2020, 36:12, 2037-2046. https://doi.org/10.1080/03007995.2020.1832058 PMid:33012210
Published
Abstract Display: 590
PDF Downloads: 548
PDF Downloads: 132 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.